Cash · 2013–2025

Beone Medicines cash

$4.5B+73.1% · FY2025

Beone Medicines (ONC) reported $4.5B in cash for fiscal 2025, +73.1% year on year.

$3.9M2013$13.9M2014$17.9M2015$87.5M2016$240M2017$713M2018$618M2019$1.4B2020$4.4B2021$3.9B2022$3.2B2023$2.6B2024$4.5B2025
Beone Medicines — Cash, 2013–2025
Fiscal yearCashChangeFiling
FY20252025-12-31$4.5B+73.1%Open →
FY20242024-12-31$2.6B−17.2%Open →
FY20232023-12-31$3.2B−18.0%Open →
FY20222022-12-31$3.9B−11.6%Open →
FY20212021-12-31$4.4B+216.6%Open →
FY20202020-12-31$1.4B+123.6%Open →
FY20192019-12-31$618M−13.3%Open →
FY20182018-12-31$713M+197.6%Open →
FY20172017-12-31$240M+173.8%Open →
FY20162016-12-31$87.5M+389.8%Open →
FY20152015-12-31$17.9M+28.6%Open →
FY20142014-12-31$13.9M+254.0%Open →
FY20132013-12-31$3.9M—Open →

Cash — Cash and cash equivalents is money available immediately at the balance-sheet date. It excludes short-term investments, which many large companies hold far more of.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2013–2025 compound annual growth +80.0%

Cash at companies of similar size

Full ranking by cash →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Beone Medicines cash |url=https://companiesranked.com/en/company/beone-medicines/cash-on-hand |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Beone Medicines cash. CompaniesRanked. https://companiesranked.com/en/company/beone-medicines/cash-on-hand

BibTeX

@misc{companiesranked-en-company-beone-medicines-cash-on-hand-2026,
  author       = {{CompaniesRanked}},
  title        = {{Beone Medicines cash}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/beone-medicines/cash-on-hand}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-Q · 0001628280-26-052878 · August 5, 2026

{{cite web |title=Beone Medicines cash — 10-Q (0001628280-26-052878) |url=https://www.sec.gov/Archives/edgar/data/1651308/000162828026052878/bgne-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-05}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Beone Medicines overview